open access
Materials and Methods
Study population. We selected participants enrolled in the New York site of the BCFR with available DNA (
8-
18).
Enrollment eligibility for participants in the parent study included
having to meet one of the following criteria: i) A
female relative who had been diagnosed with either
breast or ovarian cancer prior to the age of 45; ii) A female relative
who has been diagnosed with breast and ovarian
cancer at any age; iii) Two or more female relatives who had been
diagnosed
with breast or ovarian cancer after the age of 45;
iv) A male relative diagnosed with breast cancer at any age; v) A known
carrier of
BRCA1 or
2 mutation.
We used data collected at baseline through epidemiologic and family
history questionnaires on demographics, ethnicity,
history of all cancers, smoking, alcohol
consumption, reproductive history, hormone use, height, weight, physical
activity
and dietary intake. Blood was collected at the time
of recruitment, on average 5 years after diagnosis of cases (
19). The current study includes 313 sister-sets (n=744) consisting of sisters discordant for breast cancer.
In conclusion, in our family-based case-control study,
we observe an
increase in breast cancer risk due to alleles typically
associated with Lynch syndrome cancers. These
findings suggest that, while polymorphisms in MMR have, thus far, not
been associated
with sporadic breast cancer, deficiencies in this
pathway may be relevant in familial breast cancer.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.